Ozempic Is About to Go Generic in India, China and Canada
NYT - World
In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
Continue reading on the source website
To respect copyrights, we only provide a brief summary. Read the full article on NYT - World.
Read Full Article